Skip to content

Harrow HROW Unrecognized Tax Benefits - Impacting Effective Tax Rate

Unrecognized Tax Benefits - Impacting Effective Tax Rate at other companies

Bausch + Lomb logo
Bausch + LombBLCO
$62M+12.7%
Bausch Health Companies logo
Bausch Health CompaniesBHC
$372M-10.8%
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$0

Other financials

Income statement

See full
Revenue$44.2M-7.6%
Gross profit$27.0M-16.3%
Operating income-$22.1M-96.6%
Net income-$27.6M-55.2%
EPS (diluted)-$0.74-48.0%

Balance sheet

See full
Cash & equivalents$94.6M+41.8%
Total debt$308.6M-32.9%
Total equity$28.7M-49.1%
Total assets$419.5M+15.2%

Cash flow

See full
Operating cash flow-$9.0M-146%
CapEx$194.0K+14.1%
Free cash flow-$9.2M-147%

Valuation

See full
Market cap$1.59B+38.4%

Profitability

See full
Gross margin74.1%-0.4pp
Operating margin7.3%+5.2pp
Net margin-19.8%+18.0pp
FCF margin5.7%+5.0pp

Returns & leverage

See full
Return on equity-50%+17.5pp
Debt / equity10.7×+2.6×
Current ratio2.5×+1.6×

Where this comes from

Reported directly by Harrow in its filing.

Tagged under the XBRL concept us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate.

The official record: Harrow’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harrow's unrecognized tax benefits - impacting effective tax rate.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harrow's unrecognized tax benefits - impacting effective tax rate?
Harrow (HROW) reported unrecognized tax benefits - impacting effective tax rate of $307K in Q4 2025.
What is the long-term trend for Harrow's unrecognized tax benefits - impacting effective tax rate?
Over 2 years (2023 to 2025), Harrow's unrecognized tax benefits - impacting effective tax rate has grown at a -67.0% compound annual growth rate (CAGR), from $2.82M to $307K.
What does unrecognized tax benefits - impacting effective tax rate mean?
This subset of unrecognized tax benefits represents positions that, if recognized, would directly impact the company's effective tax rate. It highlights the specific portion of tax uncertainty that carries a direct risk to the reported bottom-line tax expense. Investors monitor this to gauge the potential volatility of future tax provisions.